Safety Alert

# Title Type of news Date Link of news
153 Safety Signal of Atorvastatin and the Risk of Erectile dysfunction Signal
152 Safety Signal of Levothyroxine and Risk of Vertigo Signal
151 Safety Signal of Etoposide and Risk of Electrolyte imbalance Signal
150 Safety Signal of Amlodipine and Risk of Hyperkalaemia Signal
149 Safety Signal of Prednisolone and the Risk of Hypomagnesaemia Signal
148 Safety Signal of Cytarabine and the Risk of Tumour lysis syndrome Signal
147 New recommendations for reducing the risk of serious side effects associated with Janus kinase inhibitors in chronic inflammatory diseases. Signal
146 Safety Signal of Prednisone and the Risk of Osteonecrosis Signal
145 Safety Signal of Levofloxacin and the Risk of Dry mouth Signal
144 Safety Signal of Ibuprofen and the Risk of Renal tubular acidosis Signal
Displaying 41 - 50 of 195